Takeda Pharmaceutical
TAK
#332
Rank
HK$545.21 B
Marketcap
HK$170.65
Share price
1.68%
Change (1 day)
55.61%
Change (1 year)

Earnings for Takeda Pharmaceutical (TAK)

Earnings in 2026 (TTM): HK$3.97 Billion

According to Takeda Pharmaceutical's latest financial reports the company's current earnings are HK$29.55 Billion. In 2025 the company made an earning of HK$26.06 Billion, an increase over its 2024 earnings that were of HK$17.49 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Takeda Pharmaceutical from 2009 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) HK$3.97 B-84.77%
2025 HK$26.06 B49.03%
2024 HK$17.49 B-2.41%
2023 HK$17.92 B-28.14%
2022 HK$24.94 B-40.9%
2021 HK$42.20 B78.24%
2020 HK$23.67 B246.1%
2019 HK$6.84 B-48.79%
2018 HK$13.35 B-23.64%
2017 HK$17.49 B21.7%
2016 HK$14.37 B-253.01%
2015 -HK$9.4 Billion-159.65%
2014 HK$15.74 B13%
2013 HK$13.93 B2.46%
2012 HK$13.60 B-57.05%
2011 HK$31.66 B-10.49%
2010 HK$35.37 B-3.99%
2009 HK$36.84 B

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
HK$146.75 B 3,523.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
HK$99.10 B 2,347.22%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
HK$54.62 B 1,248.75%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
HK$86.63 B 2,039.26%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
HK$61.04 B 1,407.47%๐Ÿ‡ซ๐Ÿ‡ท France
Merck
MRK
HK$52.70 B 1,201.32%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
HK$56.08 B 1,284.84%๐Ÿ‡ฌ๐Ÿ‡ง UK
Seagen
SGEN
-HK$6.2 Billion-253.03%๐Ÿ‡บ๐Ÿ‡ธ USA
Dr. Reddy's Laboratories
RDY
HK$3.35 B-17.25%๐Ÿ‡ฎ๐Ÿ‡ณ India